Group Psychotherapy for People With HIV
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00186550 |
Recruitment Status :
Completed
First Posted : September 16, 2005
Last Update Posted : December 4, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV Depression Risk-taking Pain | Behavioral: Supportive Expressive Group Psychotherapy Behavioral: Education | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 186 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | An Evaluation of Group Psychotherapy for People With HIV |
Actual Study Completion Date : | November 2000 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 1) a positive HIV diagnosis (either symptomatic or asymptomatic), 2) at least eighteen years of age, 3) English language skill (to complete questionnaires and participate, if assigned, to the group psychotherapy condition) and, 4) geographical proximity to groups in order to attend if assigned.
Exclusion Criteria:
- 1) severe psychiatric disorders (i.e. schizophrenia or other psychotic disorders)who would not be appropriate for participating in the group intervention, 2) active tuberculosis, 3) acute intoxication, 4) participation in an ongoing HIV/AIDS support group or 5) suicidal/homicidal ideation.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00186550
United States, California | |
Stanford University | |
Stanford, California, United States, 94305 |
Principal Investigator: | David Spiegel, M.D. | Stanford University |
Other Publications:
Responsible Party: | David Spiegel, Jack, Lulu & Sam Willson Professor, Stanford University |
ClinicalTrials.gov Identifier: | NCT00186550 |
Other Study ID Numbers: |
R01MH054930-04 ( U.S. NIH Grant/Contract ) R01MH054930-04 ( U.S. NIH Grant/Contract ) |
First Posted: | September 16, 2005 Key Record Dates |
Last Update Posted: | December 4, 2013 |
Last Verified: | December 2013 |
Depression Behavioral Symptoms |